142 related articles for article (PubMed ID: 27206104)
1. Analytical characterization of in vitro refolding in the quality by design paradigm: Refolding of recombinant human granulocyte colony stimulating factor.
Pathak M; Dixit S; Muthukumar S; Rathore AS
J Pharm Biomed Anal; 2016 Jul; 126():124-31. PubMed ID: 27206104
[TBL] [Abstract][Full Text] [Related]
2. Optimization of a refolding step for a therapeutic fusion protein in the quality by design (QbD) paradigm.
Bade PD; Kotu SP; Rathore AS
J Sep Sci; 2012 Nov; 35(22):3160-9. PubMed ID: 23086665
[TBL] [Abstract][Full Text] [Related]
3. Production of recombinant human G-CSF from non-classical inclusion bodies in Escherichia coli.
Trinh NTM; Thuoc TL; Thao DTP
Braz J Microbiol; 2021 Jun; 52(2):541-546. PubMed ID: 33483893
[TBL] [Abstract][Full Text] [Related]
4. Refolding of Proteins Expressed as Inclusion Bodies in E. coli.
Sharma R; Anupa A; Rathore AS
Methods Mol Biol; 2023; 2617():201-208. PubMed ID: 36656526
[TBL] [Abstract][Full Text] [Related]
5. Refolding of recombinant human granulocyte colony stimulating factor: effect of cysteine/cystine redox system.
Tiwari K; Shebannavar S; Kattavarapu K; Pokalwar S; Mishra MK; Chauhan UK
Indian J Biochem Biophys; 2012 Aug; 49(4):285-8. PubMed ID: 23077791
[TBL] [Abstract][Full Text] [Related]
6. High recovery refolding of rhG-CSF from Escherichia coli, using urea gradient size exclusion chromatography.
Wang C; Wang L; Geng X
Biotechnol Prog; 2008; 24(1):209-13. PubMed ID: 18179225
[TBL] [Abstract][Full Text] [Related]
7. A high-throughput protein refolding screen in 96-well format combined with design of experiments to optimize the refolding conditions.
Dechavanne V; Barrillat N; Borlat F; Hermant A; Magnenat L; Paquet M; Antonsson B; Chevalet L
Protein Expr Purif; 2011 Feb; 75(2):192-203. PubMed ID: 20851186
[TBL] [Abstract][Full Text] [Related]
8. Glycerol-assisted hydrophobic interaction chromatography improving refolding of recombinant human granulocyte colony-stimulating factor.
Wang F; Liu Y; Ma G; Su Z
Appl Biochem Biotechnol; 2009 Dec; 159(3):634-41. PubMed ID: 19169864
[TBL] [Abstract][Full Text] [Related]
9. [Refolding and purification of recombinant human granulocyte colony-stimulating factor from Escherichia coli by using protein folding liquid chromatography].
Wang C; Wang L; Geng X
Se Pu; 2007 Jul; 25(4):514-7. PubMed ID: 17970109
[TBL] [Abstract][Full Text] [Related]
10. Improved Production and Characterization of Recombinant Human Granulocyte Colony Stimulating Factor from E. coli under Optimized Downstream Processes.
Vemula S; Thunuguntla R; Dedaniya A; Kokkiligadda S; Palle C; Ronda SR
Protein Expr Purif; 2015 Apr; 108():62-72. PubMed ID: 25659501
[TBL] [Abstract][Full Text] [Related]
11. Protein recovery from inclusion bodies of Escherichia coli using mild solubilization process.
Singh A; Upadhyay V; Upadhyay AK; Singh SM; Panda AK
Microb Cell Fact; 2015 Mar; 14():41. PubMed ID: 25889252
[TBL] [Abstract][Full Text] [Related]
12. Expression and purification of recombinant human granulocyte colony-stimulating factor in fed-batch culture of Escherichia coli.
Kim CK; Choi JH; Lee SB; Lee SM; Oh JW
Appl Biochem Biotechnol; 2014 Mar; 172(5):2425-35. PubMed ID: 24390866
[TBL] [Abstract][Full Text] [Related]
13. Microfluidic chips with multi-junctions: an advanced tool in recovering proteins from inclusion bodies.
Yamaguchi H; Miyazaki M
Bioengineered; 2015; 6(1):1-4. PubMed ID: 25531187
[TBL] [Abstract][Full Text] [Related]
14. Optimization of human granulocyte macrophage-colony stimulating factor (hGM-CSF) expression using asparaginase and xylanase gene's signal sequences in Escherichia coli.
Khasa YP; Khushoo A; Tapryal S; Mukherjee KJ
Appl Biochem Biotechnol; 2011 Sep; 165(2):523-37. PubMed ID: 21562804
[TBL] [Abstract][Full Text] [Related]
15. Refolding techniques for recovering biologically active recombinant proteins from inclusion bodies.
Yamaguchi H; Miyazaki M
Biomolecules; 2014 Feb; 4(1):235-51. PubMed ID: 24970214
[TBL] [Abstract][Full Text] [Related]
16. Refolding of inclusion body proteins from E. coli.
Su Z; Lu D; Liu Z
Methods Biochem Anal; 2011; 54():319-38. PubMed ID: 21954784
[No Abstract] [Full Text] [Related]
17. High pH solubilization and chromatography-based renaturation and purification of recombinant human granulocyte colony-stimulating factor from inclusion bodies.
Li M; Fan H; Liu J; Wang M; Wang L; Wang C
Appl Biochem Biotechnol; 2012 Mar; 166(5):1264-74. PubMed ID: 22212394
[TBL] [Abstract][Full Text] [Related]
18. Effect of surface histidine mutations and their number on the partitioning and refolding of recombinant human granulocyte-colony stimulating factor (Cys17Ser) in aqueous two-phase systems containing chelated metal ions.
Zaveckas M; Zvirbliene A; Zvirblis G; Chmieliauskaite V; Bumelis V; Pesliakas H
J Chromatogr B Analyt Technol Biomed Life Sci; 2007 Jun; 852(1-2):409-19. PubMed ID: 17339136
[TBL] [Abstract][Full Text] [Related]
19. Mutation of surface-exposed histidine residues of recombinant human granulocyte-colony stimulating factor (Cys17Ser) impacts on interaction with chelated metal ions and refolding in aqueous two-phase systems.
Zaveckas M; Luksa V; Zvirblis G; Chmieliauskaite V; Bumelis V; Pesliakas H
J Chromatogr B Analyt Technol Biomed Life Sci; 2003 Mar; 786(1-2):17-32. PubMed ID: 12650998
[TBL] [Abstract][Full Text] [Related]
20. Refolding in the modern biopharmaceutical industry.
Buscajoni L; Martinetz MC; Berkemeyer M; Brocard C
Biotechnol Adv; 2022 Dec; 61():108050. PubMed ID: 36252795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
